RxDoctor Payments Data

David Boudreault

Palo Alto, CANPI 1609057884

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $8,725 of the $13,813 with a category attached, or 63.2%. AbbVie accounts for 72.6% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2020 at $3,552 and has fallen 56.7% since, to $1,537 in 2025.

$13,813in general payments, 2019–2025

Across 257 payments — averaging $53.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$10K
  • Sientra, Inc.$1K
  • Apyx Medical Corporation$1K
  • Mentor Worldwide LLC$425
  • Tepha Inc$273
  • Galderma Laboratories, L.p.$228
  • plus $463 from 7 others

What the payments were for

  • Consulting fees$2,40017%
  • Speaking & faculty fees$1,0798%
  • Travel & lodging$1,53311%
  • Food & beverage$8,72563%
  • Education$761%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Where these figures come from

Is this you, or does something look wrong? →